FDA Inspection 1146853 — REATA PHARMACEUTICALS
The FDA completed an inspection of REATA PHARMACEUTICALS on July 13, 2021 in Plano, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 13, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Plano, TX (United States)
Additional Details
Sponsor, Contract Research Organization